About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 868742, 6 pages
http://dx.doi.org/10.1155/2013/868742
Research Article

Chronic Stress Induces Structural Alterations in Splenic Lymphoid Tissue That Are Associated with Changes in Corticosterone Levels in Wistar-Kyoto Rats

1Laboratorio de Psicoinmunología, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente, 14370 Tlalpan, DF, Mexico
2Laboratorio de Farmacología Conductual, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente, 14370 Tlalpan, DF, Mexico
3Department of Neuropathology, National Institute of Neurology and Neurosurgery, 14269 Mexico City, DF, Mexico
4Departamento de Inmunología, Instituto Nacional de Cardiología, 14080 México, DF, Mexico
5Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 70228 México, DF, Mexico
6Departamento de Inmunología de la Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, 11340 México, DF, Mexico
7Departamento de Investigación Experimental y Bioterio, Instituto Nacional de Ciencias Médicas y Nutrición, 14000 México, DF, Mexico
8Laboratory of Surgical Pathology, The American British Cowdray Medical Center, 01120 Mexico City, DF, Mexico

Received 25 November 2012; Accepted 2 January 2013

Academic Editor: George E. Plopper

Copyright © 2013 María Eugenia Hernandez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Gouin, L. Hantsoo, and J. K. Kiecolt-Glaser, “Immune dysregulation and chronic stress among older adults: a review,” NeuroImmunoModulation, vol. 15, no. 4-6, pp. 251–259, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Blume, S. D. Douglas, and D. L. Evans, “Immune suppression and immune activation in depression,” Brain, Behavior, and Immunity, vol. 25, no. 2, pp. 221–229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Tejani-Butt, W. P. Pare, and J. Yang, “Effect of repeated novel stressors on depressive behavior and brain norepinephrine receptor system in Sprague-Dawley and Wistar Kyoto (WKY) rats,” Brain Research, vol. 649, no. 1-2, pp. 27–35, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Reynolds, “Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis,” Psychoneuroendocrinology, vol. 38, no. 1, pp. 1–11, 2013. View at Publisher · View at Google Scholar
  5. V. Locatelli, E. Bresciani, L. Tamiazzo, and A. Torsello, “Central nervous system-acting drugs influencing hypothalamic-pituitary- adrenal axis function,” Endocrine Development, vol. 17, pp. 108–120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Olff, Y. Güzelcan, G. J. de Vries, J. Assies, and B. P. R. Gersons, “HPA- and HPT-axis alterations in chronic posttraumatic stress disorder,” Psychoneuroendocrinology, vol. 31, no. 10, pp. 1220–1230, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Rivest, “Interactions between the immune and neuroendocrine systems,” Progress in Brain Research, vol. 181, pp. 43–53, 2010. View at Scopus
  8. C. Kiank, J. P. Zeden, S. Drude et al., “Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans,” PLoS One, vol. 5, no. 7, Article ID e11825, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Pavon, G. Sandoval-Lopez, M. Eugenia Hernandez et al., “Th2 cytokine response in major depressive disorder patients before treatment,” Journal of Neuroimmunology, vol. 172, no. 1-2, pp. 156–165, 2006. View at Publisher · View at Google Scholar
  10. M. E. Hernández, D. Mendieta, D. Martínez-Fong et al., “Variations in circulating cytokine levels during 52week course of treatment with SSRI for major depressive disorder,” European Neuropsychopharmacology, vol. 18, no. 12, pp. 917–924, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. I. J. Elenkov, “Glucocorticoids and the Th1/Th2 balance,” Annals of the New York Academy of Sciences, vol. 1024, pp. 138–146, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Michel and M. Cabanac, “Effects of dexamethasone on the body weight set point of rats,” Physiology and Behavior, vol. 68, no. 1-2, pp. 145–150, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. T. F. Heatherton, J. Polivy, and C. P. Herman, “Restraint, weight loss, and variability of body weight,” Journal of Abnormal Psychology, vol. 100, no. 1, pp. 78–83, 1991. View at Publisher · View at Google Scholar · View at Scopus
  14. M. N. Silverman and E. M. Sternberg, “Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction,” Annals of the New York Academy of Sciences, vol. 1261, pp. 55–63, 2012. View at Publisher · View at Google Scholar
  15. R. S. Chriguer, L. L. K. Elias, I. M. D. Silva, J. G. H. Vieira, A. C. Moreira, and M. De Castro, “Glucocorticoid sensitivity in young healthy individuals: in vitro and in vivo studies,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 11, pp. 5978–5984, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Domínguez-Gerpe and M. Rey-Méndez, “Alterations induced by chronic stress in lymphocytes subsets of blood and primary and secondary immune organs of mice,” BMC Immunology, vol. 2, article 7, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. I. I. Bobyntsev, A. A. Dolzhikov, and L. A. Sever'yanova, “Morphological changes in immune and endocrine organs of stressed mice after administration of a gonadotropin-releasing hormone analogue,” Bulletin of Experimental Biology and Medicine, vol. 144, no. 5, pp. 744–747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. I. I. Bobyntsev, A. A. Dolzhikov, and L. A. Sever'yanova, “Morphological changes in immune and endocrine organs of mice injected with a gonadotropin-releasing hormone analog,” Bulletin of Experimental Biology and Medicine, vol. 139, no. 1, pp. 101–104, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Dirks, L. Groenink, J. A. Bouwknecht et al., “Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations,” European Journal of Neuroscience, vol. 16, no. 9, pp. 1751–1760, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Pruett, P. Hébert, J. M. Lapointe, W. Reagan, M. Lawton, and T. T. Kawabata, “Characterization of the action of drug-induced stress responses on the immune system: evaluation of biomarkers for drug-induced stress in rats,” Journal of Immunotoxicology, vol. 4, no. 1, pp. 25–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. N. Aucott, “Glucocorticoids and infection,” Endocrinology and Metabolism Clinics of North America, vol. 23, no. 3, pp. 655–670, 1994.
  22. Y. H. Qiu, Y. P. Peng, C. Cheng, and L. Dai, “Time effect of restraint stress-induced suppression of lymphocyte transformation,” Acta Physiologica Sinica, vol. 51, no. 4, pp. 477–480, 1999. View at Scopus
  23. C. G. Leandro, T. Martins De Lima, A. Folador et al., “Physical training attenuates the stress-induced changes in rat T-lymphocyte function,” NeuroImmunoModulation, vol. 13, no. 2, pp. 105–113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Sterzer, G. J. Wiegers, and J. M. H. M. Reul, “Long-term in vivo administration of glucocorticoid hormones attenuates their capacity to accelerate in vitro proliferation of rat splenic T cells,” Endocrinology, vol. 145, no. 8, pp. 3630–3638, 2004. View at Publisher · View at Google Scholar · View at Scopus